Cervical cancer prevention relies on a dual strategy: HPV vaccination and organized screening. January, a month dedicated to awareness, reminds us that cervical cancer is among the most preventable cancers, provided that tools are accessible to the population and ongoing programs are implemented.
In Italy, according to AIOM, there will be an estimated 2,382 new diagnoses in 2024 (1.3% of cancers in women), and approximately 49,800 women will live after a diagnosis. HPV, a highly prevalent virus, is responsible for almost all cases and also contributes to other related cancers.
Screening protocols are defined: Pap smear every three years from age 25; HPV-DNA testing as the primary screening for people over age 30, every five years. However, the impact depends on the entire process: invitations, recalls, further investigations, and follow-up.
In this context, Soluzioni Integrate Maggioli supports the digitalization of prevention programs with interoperable healthcare platforms and scalable HIT solutions, which structure and secure data and ensure continuity of clinical and administrative services, facilitating the traceability of steps and operational management in the area.
Prevention also means measurement: updated data helps identify under-coverage areas, address critical issues, and strengthen equitable access. With structured and long-term monitored processes, prevention becomes stable, measurable, and more relevant to individuals.